β-Arrestin2 influences the response to methadone in opioid-dependent patients
- 1 June 2010
- journal article
- research article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 11 (4) , 258-266
Abstract
β-Arrestin2 (ARRB2) is a component of the G-protein-coupled receptor complex and is involved in μ-opioid and dopamine D2 receptor signaling, two central processes in methadone signal transduction. We analyzed 238 patients in methadone maintenance treatment (MMT) and identified a haplotype block (rs34230287, rs3786047, rs1045280 and rs2036657) spanning almost the entire ARRB2 locus. Although none of these single nucleotide polymorphisms (SNPs) leads to a change in amino-acid sequence, we found that for all the SNPs analyzed, with exception of rs34230287, homozygosity for the variant allele confers a nonresponding phenotype (n=73; rs1045280C and rs2036657G: OR=3.1, 95% CI=1.5–6.3, P=0.004; rs3786047A: OR=2.5, 95% CI=1.2–5.1, P=0.02) also illustrated by a 12-fold shorter period of negative urine screening (P=0.01). The ARRB2 genotype may thus contribute to the interindividual variability in the response to MMT and help to predict response to treatment.Keywords
This publication has 47 references indexed in Scilit:
- A Test for Genetic Association that Incorporates Information about Deviation from Hardy-Weinberg Proportions in CasesThe American Journal of Human Genetics, 2008
- ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependenceHuman Molecular Genetics, 2008
- Modulation of voluntary ethanol consumption by beta‐arrestin 2The FASEB Journal, 2008
- In vitro P-Glycoprotein-Mediated Transport of (R)-, (S)-, (R,S)-Methadone, LAAM and Their Main MetabolitesPharmacology, 2007
- β-Arrestins 1 and 2 are associated with nicotine dependence in European American smokersMolecular Psychiatry, 2007
- 5′ UTR polymorphism of dopamine receptor D1 (DRD1) associated with severity and temperament of alcoholismBiochemical and Biophysical Research Communications, 2007
- An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and BehaviorCell, 2005
- Interindividual Variability of the Clinical Pharmacokinetics of MethadoneClinical Pharmacokinetics, 2002
- Direct binding of β‐arrestins to two distinct intracellular domains of the δ opioid receptorJournal of Neurochemistry, 2001
- Detecting Marker-Disease Association by Testing for Hardy-Weinberg Disequilibrium at a Marker LocusThe American Journal of Human Genetics, 1998